Medistim ASA (OSL:MEDI)

Market Cap	3.82B +32.9%
Revenue (ttm)	662.18M +22.2%
Net Income	142.42M +40.1%
EPS	7.79 +40.3%
Shares Out	18.28M
PE Ratio	26.84
Forward PE	23.69
Dividend	6.00 (2.87%)
Ex-Dividend Date	May 9, 2025

Volume	14,529
Average Volume	33,271
Open	211.00
Previous Close	209.00
Day's Range	207.00 - 214.00
52-Week Range	150.00 - 292.00
Beta	1.07
RSI	43.03
Earnings Date	Feb 27, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.